Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Mackenzie

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Pharmacology|November 11, 1999
Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptorsE M Lutz, C J MacKenzie, M Johnson, et al.
Annals of the New York Academy of Sciences|December 26, 1996
Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1E M Lutz, C J MacKenzie, J Morrow, et al.
Endocrinology|August 31, 2000
Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cellsM S Johnson, E M Lutz, C J MacKenzie, et al.
Molecular Pharmacology|May 17, 2001
ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variantD A McCulloch, E M Lutz, M S Johnson, et al.
Biochemical Society Transactions|August 28, 2002
Additional signals from VPAC/PAC family receptorsD A McCulloch, C J MacKenzie, M S Johnson, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Pharmacology|November 11, 1999
Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptorsE M Lutz, C J MacKenzie, M Johnson, et al.
Annals of the New York Academy of Sciences|December 26, 1996
Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1E M Lutz, C J MacKenzie, J Morrow, et al.
Endocrinology|August 31, 2000
Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cellsM S Johnson, E M Lutz, C J MacKenzie, et al.
Molecular Pharmacology|May 17, 2001
ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variantD A McCulloch, E M Lutz, M S Johnson, et al.
Biochemical Society Transactions|August 28, 2002
Additional signals from VPAC/PAC family receptorsD A McCulloch, C J MacKenzie, M S Johnson, et al.
Pageof 4